Tackling health inequalities: Why they matter
Health inequalities have deep roots and no single cause, driven by a complex mix of factors. These include:1
Variable access to healthcare
Delays in diagnosis
Lack of early intervention
Environmental and social factors (e.g., housing, education, income)
The COVID-19 pandemic highlighted the scale of these disparities. People from ethnic minority backgrounds, those with long-term health conditions, and individuals in the most deprived areas face both higher mortality and more severe illness.2
At Novartis UK, we use science-based innovation to reimagine how medicines are developed and accessed – driven by our belief that no one should have to wait for a better quality of life.
We recognise our responsibility to help reduce health inequalities, working in partnership with policymakers, healthcare systems, and local communities to create lasting change.
Our action
Our pledge is underpinned by 4 key pillars:
We partner with healthcare systems to identify population groups most at risk of poor health. Through data analysis and risk stratification, we aim to support screening for earlier diagnosis and timely intervention.
We co-create solutions with healthcare partners to improve access to diagnostics, preventive care, digital tools, and health literacy support for underserved communities.
We collaborate with the UK research community to improve patient engagement and ensure people from all backgrounds have the opportunity to participate in clinical research.
We equip our teams with the tools, insights, and training needed to work meaningfully with healthcare systems and leaders – helping to shape patient services and develop workforce capability to narrow health inequalities at both system and local levels.
At Novartis UK, we see it as both our responsibility and opportunity to drive positive social change by making health equity central to our mission. We work with governments, healthcare providers, patient groups, and communities to reduce health inequalities. Our influence extends beyond medicines – through inclusive hiring, responsible investment, promoting diversity, and supporting sustainability. See 10 Ways Novartis is Working to Reduce Health Inequalities.
